FDA Approves Viibryd Tablets To Treat Major Depressive Disorder

The Food and Drug Administration Jan. 21 approved Viibryd tablets (vilazodone hydrochloride) to treat major depressive disorder in adults.

Viibryd, which is manufactured by New Haven, Conn.-based PGxHealth, will be available in 10 mg, 20 mg, and 40 mg tablets, FDA said. Viibryd and all other antidepressant drugs have a boxed warning and a patient medication guide describing the increased risk of suicidal thinking and behavior in children, adolescents, and young adults ages 18 to 24 during initial treatment.

The warning also says data did not show this increased risk in adults older than 24 and that patients ages 65 ...